Interaction between heterologous receptor tyrosine kinases Hormone-stimulated insulin receptors activate unoccupied IGF-I receptors by Tartare, Sophie et al.
Volume 295, number 1,2,3, 219-222 FEBS 10556 
Q 1991 Federation of European Biochemical Societies 00145793/9l/S3.50 
December 1991 
Interaction between heterologous receptor tyrosine kinases 
Hormone-stimulated insulin receptors activate unoccupied IGF-I receptors 
Sophie Tartare, Robert Ballotti and Emmanuel Van Obberghen 
Inslirltr Nurional de la SanrC et de Iu Reclrerche A46dicalr, INSERM UI45, Fanrh~ de MPdecitw. 06107 Nice, Cedex 2, France 
Received 8 November 1991 
To determine whcthcr heterologous rcccptor tyrosine kinases interact with each other WI: have investigaied the ability of insulin receptors to 
transphosphorylate and transactivate IGF-I rcccptors. Using partially purified receptors we show that hormone-stimulated insulin receptors 
induced a 40% increase in IGF-I receptor phosphorylation. Remarkably, this transphosphorylalion of IGF-I receptors by insulin receptors rcsultcd 
in a 2.5-fold augmentation of the IGF-I receptor tyrosinc kinase activity for substrates. Our findings demonstrate that transphosphorylation with 
:rsr~~:ivat~on can oc;‘;: bc%ze:: inz!ir, zz! !GF-! rccep!ors. WP Euould like to ,nrnpnse that such a phenomenon pyrticipatcs in the insulin-induced 
plciotropic program by mediating the growth promoting effects of the hormone. 
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I. INTRODUCTION 
Insulin and insulin-like growth factor-l (IGF-I) are 
structurally related polypeptides that elicit a similar pat- 
tern of biological effects after binding to their respective 
cell surface receptors [I]. Like their ligands, insulin re- 
ceptors and IGF-I receptors are highly homologous. 
They are heterotetrameric glycoproteins composed of 2 
extracellular a- and 2 transmembrane P-subunits [2-4]. 
Both receptors bind insulin and IGF-I, but each recep- 
tor binds its cognate ligand with a lOO-1000~fold higher 
affinity than the cross-reacting polypeptide. Interaction 
of the ligand with the cl-subunit stimulates the/&subunit 
tyrosine kinase activity leading to autophosphorylation 
of the latter and tyrosine phosphorylation of intracellu- 
lar substrates j5-61. A general consensus has now been 
reached concerning the idea that ihe receptor tyrosine 
kinase is crucial for ligand-induced signal transduction 
and generation of biological effects [7]. 
Despite their homologous structures and their over- 
iapping bioiogicai effecis, ihe insuiin and the IGF-I 
receptors eem to play significantly different physiologi- 
cal roles. The main function of insulin appears to be 
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regulation of metabolism [8], while IGF-I is considered 
to be involved chiefly in cellular proliferation and dif- 
ferentiation [9]. Generally speaking, the effects on cell 
growth seen with high concentrations of insulin can be 
accounted for by cross-binding of insulin to the IGF-I 
receptor. However, in some cell lines, which express the 
2 receptors (i.e. human skin fibroblasts and CHO-Kl 
cells), insulin seems to be mitogenic through its own 
receptor [lO,l I]. Additionally, in fibroblasts over-ex- 
pressing the human insulin receptors, it has been ob- 
served that insulin leads to mitogenesis through its own 
receptor [12,13]. Recent studies have shown that all the 
receptor-linked tyrosine kinascs analyzed so far, includ- 
ing the EGF [14,15], PDGF [16], CSF-I [17] and insulin 
receptor [18,19], appear to use a similar activation 
mechanism involving intermolecular interaction of ho- 
moiogous cytoplasmic domains. Based on this prevail- 
ing idea that intermolecular transphosphorylation oc- 
curs amongst homologous tyrosine kinase receptors, we 
hypothesized that it might also take place amongst heter- 
ologotis, tint iciGXd, MI-W- iCCC~ On ~JLVYSSSI a..~...~_~. .._-._ t r trrme;n#3 t;na.Pf 
specifically, we investigated whether the activated insu- 
lin receptor kinase could phosphorylate and transacti- 
vate the !GF-I receptor. Such a heterologous receptor 
cross-talk could explain, at least in some cell systems, 
the stimulating effects of insulin on cell proliferation. To 
test this idea, we have studied in the present report, the 
ability of insulin receptors to interact with IGF-I recep- 
tors. Using a cell-free phosphorylation assay we demon- 
strate that hormone-stimulated insulin receptors indeed 
can transphosphorylate, and more importantly, trans- 
activate IGF-I receptors. Based on these data we would 
like to suggest that such a transaclivation mechanism 
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may play a role in mediating mitogenic responses of 
insulin, and as such explain at least in part the plei- 
otropism of insulin and related growth factors. 
2. MATERIALS AND METHODS 
3.1. /I rrr ihodicv rml cdl limbs 
Antibodies to phosphotyrosiw wcrc prcparcd as previously dc- 
scribed [20]. (rIR-3 is a murinc-specific monoclonal antibody dircctcd 
against the z-subunit or the IGF-I reccplor [2l] and was gcncrously 
provided 10 us by Dr. S. Jacobs (Wcllcomc. Research Triangle Park. 
NC. USA). NIH3T3 libroblasls. transfcctcd with aa cxprcssion plns- 
mid encoding the human insulin rcccptor and expressing 6x10” rcccp- 
tars per ccl1 [?I!]. were a gilt from Dr. J. Whillaker (Stony Brook. NY. 
USA). NIH3T3 fibroblasls transfccted with an cxprcssion plasmid 
encoding die human IGF-I rcccplor and having I .5x10’ cell surl-acc 
rcccplors wcrc provided 10 us by Dr. P. DC Mcyts (Hagcdorn Institu& 
Copcnhagcn. Denmark). 
2.2. P,c-~~lrn.~~~lro,:l’Itrrir,,~ 0J imrribr reccpro,?; 
Insulin reccplors partially purilicd by wheat germ agglulin!n chrom- 
atography as previously dcscribcd [13] wcrc incubated without or wi!h 
insulin (IO.” M) for I hat room wnpcraturc and then prc-phosphoryl- 
md with unlabclcd ATP (I j,uuXl), MgC12 (8 mM) and MnCi, (4 myvi). 
Aficr 30 min at rhc WIIIC tcmpcralurc. ~hc reaction was slopped by 
addition ofa solution conlaining(0.1 %l NaF. 20 mM EDTA. 0.1 m%l 
ZnCI$ Thcsc insulin rcccplors were immunoprccipitalcd using aTfin- 
ity-purified anlibodics 10 phojpholyrosinc prc-bawd on protein A- 
scpharosc for !I0 min al 4°C. The immune complexes were washed 3 
limes in HNT bulTcr (HKT: 30 1nb1 NaCI. 30 mM HEPES. pH 7.5. 
0. I % Trilon X-100) ;md lyrosinc phosphorylalcd rcccplors wcrc clued 
wilh 30 mM 4-nilrophcnyl phosphate. 
An clum containing prc-phosphorylalcd insulin rcccplors was 
added to partially purilicd IGF-I rcccpiors and phosphorylaiion was 
initiated by the addition of IO PCi or [y-“P]ATP (3000 Ci!mmol) in 
the prcscncc of 5 mhl MnCI,. IO m?vl hlg(CH,C00)2, 5 jrhl ATP and 
IO @l/ml of poly-L-lysinc as described [34]. Alicr I5 min. IGF-I 
rcccptors wcrc ilnlllulloprccipilil~ed using aIR-3 as outlined abovc. 
The immunoprccipitaws wcrc washed 3 limes with high salt buTrcr (0.5 
Al NaCI. 30 m!vl HEPES. pH 7.5.0.18 Tri!on X-100) and 3 times ia 
HNT burrcr. Finall>-. the rcccplors wcrc analyzed by SDS-PAGE 
under reducing condilions and visudlizcd by auloradiography. For lhc 
tyrosinc kinasc activity assay. IGF-I rcccplors wcrc phosphorylawd 
in the same way as above. Aficr immunoprccipitation with antibodies 
LO rcccplor. the washed pcllcl ws incubated in 50~1 of HNT buriizr. 
Phosphoryla~ion oflhc subslrw. poly(Glu:Tyr) (0.3 m&ml), was ini- 
tiatcd by adding 2.5 PCi oT [y-?‘P]ATP, IO mM Xlg(CH,COO),. and 
50@1 ATP. Artcr I5 min the silmplcs wcrc spotted on Whatman 3h1 
paper. prccipiwtcd in 10% wichloroacclic acid. Sa,P!O, (5 mM) and 
ihc rudiu&viiy ivas cs;imaisd by Chcrcnkov co;:nting. 
3. RESULTS AND DISCUSSION 
In a first series of in vitro experiments we have ad- 
dressed the question of whether insulin receptors were 
able to transphosphorylnte IGF-I receptors. The insulin 
receptor was treated without or with insulin, and then 
phosphorylated with unlabeled ATP in order to activate 
its tyrosine kinase activity. After immunoprccipitation 
with antibodies to phosphotyrosine and elution with 
4-nitrophenyl phosphate, pre-phosphorylatcd insulin 
receptor was added to bi\sal IGF-I receptor. Then phos- 
phorylation ofrcceptoss was performed in the presence 
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Fig. I. Transphosphorylation or IGF-I receptors by insulin receptors. 
Partially purilicd IGF-I rcccplors wcrc incubated in lhc abscncc (lane 
I) or prcscncc of basil prc-phosphorylalcd iR (lane 2) or stimulalcd 
prc-phosphorylatcd IR (law 3) as described in Materials and Mclh- 
ods. TIIC rcccplors wcrc lhcn allowed to phosphorylatc upon addhion 
or a l$?P]ATP mixlurc. Thcrcaliur. the reccplors wcrc subjcclcd to 
immunoprccipitalion with antibody 10 IGF-I rcceplor (clR-3). AIicr 
cxtcnsivc washes ibc 3 samples were analyzed on lhc same gel by 
SDS-PAGE under reducing conditions. The gel wasdricd and cxposcd 
10 Kodak X-AR film for 5 Ii ;II -70°C. An auloradiogram of his gel 
is shown (IR: insulin rcccplor). Note that ~hc same cxpcrimcnt was 
pcrformcd on 3 difI?rcnl occasions, and comparable results wcrc 
round. 
of labeled ATP and poly-L-lysine as described [24]. 
After immunoprecipitation with aIR-3, a specific anti- 
body directed against the IGF-! receptor a-subunit, the 
phosphoproteins were analyzed by SDS-PAGE under 
reducing conditions (Fig. I). When the IGF-I receptor 
was incubated solely with a labeled ATP mixture we 
observed a basal level of receptor /3-subunit autophos- 
phorylation (Fig. I, lane I). Addition of activated in- 
sulin receptor induced a 40% augmentation of IGF-I 
receptor phosphorylaiion (Fig. I. lane 3). This increase 
in phosphorylation could have been due to a co-pre- 
cipitation of insulin receptors (re-phosphorylated with 
labeled ATP) and IGF-I receptors. However. we were 
able to rule out this possibility. Indeed, when we per- 
formed prc-phosphorylation of insulin receptors with 
labeled ATP and transphosphorylation of IGF-I recep- 
tors with unlabeled ATP, no “‘P-labeled insulin re- 
ceptors were precipi!ated by aIR-3, indicating that nei- 
ther co-precipitation nor association between the 2 par- 
tially purified rcccptors occurs (data not shown). Hence, 
our data show that in a cell-free system the IGF-I re- 
ceptor is a substrate for the insulin rcccptor. This de- 
monstrates that in!ermoleculnr phosphorylation is in- 
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Fig. 2. Tyrosinc kinase activity oT immunopreciphatcd IGF-I reccp- 
iors. Parlially purilicd IGF-I rcccptors were incubated and phospho- 
rylalcd in the presence of basal pre-phosphorylavzd IR or stimulaicd 
pre-phosphorylaicd IR (In*) as described in the Icgcnd to Fig. I. Aider 
immunoprccipilation with anlibody 10 IGF-I receptors (alR-3), the 
washed pellets were incubated in a phosphorylation assay mixture 
containing the arlificial substrate poly(Glu:Tyr) (0.2 mgIml). After I5 
rain the samples wcrc analyzed using a filler paper assay. In control 
experiments. partially purified IGF-I rcccptors wcrc incubated in the 
abscncc or prcscnce of IGF-I (IO-” M) Ibr I h at room tcmperaiurc. 
Finally phosphorylation oTpoly(Glu:Tyr) was perrormed as described 
above. The results arc the mean f SEM of 3 scparatc cxperimcnls 
whcrc each point was done in triplicate. 
deed possible between 2 heterologous, but structurally 
related molecules, such as insulin receptors and IGF-I 
receptors. Furthermore, our results provide an explana- 
tion, at the molecular level, of the observations made by 
Beguinot et al. [25] showing phosphorylation of IGF-I 
receptors upon addition of insulin to skeletal muscle 
cells. 
Similar to other tyrosine kinase receptors, tyrosine 
autophosphorylation of the IGF-I receptor is necessary 
for activation of its signaling function [7]. Indeed, it has 
been shown that autophosphorylation of the IGF-I re- 
ceptor increases its tyrosine kinase activity [26]. There- 
fore, we were interested to see whether the empty IGF-I 
receptor becomes activated upon transphosphorylation 
by the hormone-stimulated insulin receptor. To investi- 
gate this possibility, we looked at the phosphorylation 
of the substrate poly(Glu:Tyr) by IGF-I receptors trans- 
phosphorylared by insulin receptors as described above. 
Measurements of kinase actlvlty were performed after 
immunoprecipitation of IGF-I receptors by aIR-3 (Fig. 
2). In control experiments, without addition of pre- 
phosphorylated insulin receptors, we observed that 
IGF-I induced a 2-fold increase in poly(Glu:Tyr) phos- 
phorylation. Importantly, phosphorylation of IGF-I re- 
ceptors by activated insulin receptors induced a more 
pronounced enhancement of poly(Glu:Tyr) phospho- 
rylation (2.5.fold). In the absence of IGF-I receptor, we 
found no tyrosine kinase activity precipitated by orlR-3, 
which is consistent with the specificity of this antibody 
for the IGF-I receptor. Our results show thus that the 
insulin receptor can transactivate the tyrosinc kinase of 
the IGF-I receptor, possibly by a transphosphorylation 
mechanism. We would like to suggest hat such a cross- 
talk phenomenon between insulin receptors and IGF-I 
receptors occurs in living cells. 
Intermolecular transphosphorylation appears to be a 
common characteristic of receptor tyrosine kinases [ 14- 
191. For the insulin receptor, at least 2 independent 
reports support this view. In the first [18], using cells 
expressing a chimeric epidemlal growth factor/insulin 
receptor and a kinase-deficient insulin receptor, we have 
shown the occurrence of transphosphorylation between 
these 2 insulin receptor constructs. In the second, Accili 
et al. [19] have demonstrated in vitro transphosphoryla- 
tion and transactivation of a mutated insulin receptor 
by the wild-type insulin receptor. In addition to trans- 
phosphorylation and transactivation between insulin 
receptors described in these studies, our data il!ustrate 
that a similar phenomenon can also take place between 
insulin receptors and IGF-I receptors. To the best of 
our knowledge, this is the first direct demonstration of 
a transactivation amongst heterologous receptor-linked 
tyrosine kinases involving a ligand-stimulated receptor, 
the insulin receptor, and an empty receptor, the IGF-I 
receptor. Recent studies have identified, in various tis- 
sues and cell lines, the existence of insulin/IGF-I recep- 
tor heterotetramers, composed of an insulin receptor a/l 
heterodimer and an IGF-I receptor c@ heterodimer j27- 
291. Based on these observations it seems reasonable to 
imagine that transphosphorylationftransactivation 
reactions between insulin and IGF-I receptor B-sub- 
units also exist within insulin/IGF-I receptor hybrids. 
While the precise physiological significance of trans- 
phosphorylation and transactivation involving insulin 
and IGF-I receptors remains to be determined, the de- 
monstration of such receptor interactions provides us 
with a novel insight into the intricate biological effects 
evoked by the polypeptides binding to these receptors. 
We would like to propose that such phenomena may 
play a role in mediating rowth promoting responses of 
insulin, and as such explain, at least in part, the pleiotro- 
pism of insulin and related growth factors. 
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